首页 › 基金 › Michelson Medical Research Foundation, Inc. › GXC

Michelson Medical Research Foundation, Inc. 对 GXC 的持仓历史

SPDR INDEX SHS FDS

Michelson Medical Research Foundation, Inc. 在 Q3 2026 的 13F 申报中披露持有 GXC(SPDR INDEX SHS FDS)16,750 股,市值约 US$1.5M,约占其申报组合的 1.29%,在其申报持仓中市值排名第 20 位。 Michelson Medical Research Foundation, Inc. 最近 12 个申报季度中有 12 个季度披露了 GXC 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)16.75K 股
申报持仓市值$1.45M
组合权重1.29%
首次申报Q4 2023
最近变动持有
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Michelson Medical Research Foundation, Inc. 对 GXC 的持仓演变

Michelson Medical Research Foundation, Inc. 于 Q4 2023 首次披露 GXC 持仓:16,750 股(约 US$1.1M)。 该持仓在 Q3 2025 达到峰值 16,750 股,市值约 US$1.8M。 在 12 次申报中,Michelson Medical Research Foundation, Inc. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 16,750 股、市值约 US$1.5M。

逐季持仓明细

季度股数金额变化
Q4 2023 16.75K $1.14M 新进
Q1 2024 16.75K $1.10M 持有
Q2 2024 16.75K $1.15M 持有
Q3 2024 16.75K $1.38M 持有
Q4 2024 16.75K $1.27M 持有
Q1 2025 16.75K $1.44M 持有
Q2 2025 16.75K $1.47M 持有
Q3 2025 16.75K $1.76M 持有
Q4 2025 16.75K $1.62M 持有
Q1 2026 16.75K $1.56M 持有
Q2 2026 16.75K $1.45M 持有
Q3 2026 16.75K $1.45M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GXC 与 13F 数据

GXC(SPDR INDEX SHS FDS)的行业分类暂缺。我们追踪的基金中还有 22 只申报持有 GXC,申报仓位最大的包括:OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC (US$17.5M), swisspartners Advisors Ltd (US$12.9M), Prism Advisors, Inc. (US$7.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GXC 的基金

查看 GXC 的全部基金持有人 →

常见问题

How long has Michelson Medical Research Foundation, Inc. held GXC?

Michelson Medical Research Foundation, Inc. has disclosed GXC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in GXC?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 16.75K shares of GXC (SPDR INDEX SHS FDS), valued at $1.45M, representing 1.29% of its reported portfolio and ranking #20.

Has Michelson Medical Research Foundation, Inc. been buying or selling GXC?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in GXC. The position peaked in Q3 2025 at 16.75K shares.

Which other funds hold GXC?

Other major institutional holders of GXC include OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC, swisspartners Advisors Ltd, Prism Advisors, Inc., among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.